schizandrin b has been researched along with Fibrosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, G; Chen, J; Diao, LT; Du, B; Li, H; Li, S; Shi, H; Yin, P; Zhong, Y | 1 |
| Bai, X; Gu, Z; Jin, H; Miao, J; Shao, Z; Wang, Q; Wang, X; Wang, Z; Wu, J | 1 |
| Chen, T; Huang, W; Liang, G; Qian, J; Qian, Y; Wang, J; Wang, Z; Wu, G; You, S | 1 |
3 other study(ies) available for schizandrin b and Fibrosis
| Article | Year |
|---|---|
Schisandrin B attenuates renal fibrosis via miR-30e-mediated inhibition of EMT.
Topics: Actins; Cells, Cultured; Cyclooctanes; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Kidney; Lignans; MicroRNAs; Polycyclic Compounds; Snail Family Transcription Factors; Transforming Growth Factor beta1; Ureteral Obstruction; Zinc Finger E-box Binding Homeobox 2 | 2019 |
Schisandrin B attenuates epidural fibrosis in postlaminectomy rats by inhibiting proliferation and extracellular matrix production of fibroblasts.
Topics: Animals; Cell Proliferation; Cyclooctanes; Extracellular Matrix; Fibroblasts; Fibrosis; Laminectomy; Lignans; Male; Polycyclic Compounds; Rats; Rats, Sprague-Dawley | 2019 |
Schizandrin B attenuates angiotensin II induced endothelial to mesenchymal transition in vascular endothelium by suppressing NF-κB activation.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Cells, Cultured; Cyclooctanes; Cytokines; Disease Models, Animal; Endothelium, Vascular; Fibrosis; Gene Expression Regulation; Inflammation; Lignans; Male; Mice; Mice, Inbred C57BL; NF-kappa B p50 Subunit; Oxidative Stress; Phenotype; Polycyclic Compounds; Signal Transduction; Vascular Remodeling | 2019 |